[Escaping oral hypoglycemic agents in type 2 diabetes: importance and limitations of transitory optimized insulin therapy].
Leutenegger
M
M
Clinique médicale B, Hôpital Robert Debre, Reims, France.
Bertin
E
E
Grulet
H
H
D000284:Administration, Oral; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D007328:Insulin
L'échappement aux hypoglycémiants oraux du diabète de type 2: intérêts et limites de l'insulinothérapie optimisée transitoire.